Goldman sees growth catalyst for Altria Group, Inc. (MO) after FDA approval of on! FURTHER

Goldman sees growth catalyst for Altria Group, Inc. (MO) after FDA approval of on! FURTHER
Goldman sees growth catalyst for Altria Group, Inc. (MO) after FDA approval of on! FURTHER

We recently compiled a list of the Top 10 Long-Term Investments for Kids. Altria Group, Inc. ranks tenth among Better long-term investments.

TheFly reported on December 22 that Goldman Sachs analyst Bonnie Herzog highlighted a key positive catalyst for MO following regulatory progress in its modern oral nicotine portfolio. The FDA granted marketing authorization on December 21, 2025, for six on! PLUS nicotine pouch products manufactured by MO subsidiary, Helix Innovations LLC.

This approval, the first under the FDA’s new pilot program for accelerated premarket tobacco product applications (PMTA), supports Altria Group, Inc.’s (NYSE:MO) “Moving Beyond Smoking” strategy by offering a differentiated, “soft-body” pouch experience in multiple flavors and strengths (6 mg and 9 mg), improving its competitiveness against dominant rivals such as ZYN.

Goldman sees growth catalyst for Altria Group, Inc. (MO) after FDA approval of on! FURTHER
Goldman sees growth catalyst for Altria Group, Inc. (MO) after FDA approval of on! FURTHER

Jonathan Weiss/Shutterstock.com

Herzog noted that this regulatory milestone could serve as an important growth driver, positioning the corporation to expand its high-margin oral nicotine portfolio. The approval aligns with the company’s broader operational shift toward reduced-risk products while maintaining traditional revenue streams.

In contrast, BofA Securities analyst Lisa Lewandowski maintained a Buy rating on MO but lowered the price target to $64 from $66 on Dec. 19, citing evolving consumer trends and pressure from the illicit e-vapor market.

Altria Group, Inc. (NYSE:MO) is a leading American tobacco and nicotine products company headquartered in Richmond, Virginia. It is one of the largest producers and marketers of oral and smokable tobacco products in the United States, selling iconic brands such as Marlboro cigarettes, Black & Mild cigars, and smokeless products such as Copenhagen and Skoal.

While we recognize MO’s potential as an investment, we believe certain AI stocks offer greater growth potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that’s also benefiting significantly from Trump-era tariffs and the offshoring trend, check out our free report on best short-term AI stock.

READ NEXT: 30 stocks that should double in 3 years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None.

Source link